Compile Data Set for Download or QSAR
Report error Found 85 Enz. Inhib. hit(s) with all data for entry = 50016849
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174389(1-(2-Chloro-4-fluoro-benzoyl)-3-(5-hydroxy-2-metho...)
Affinity DataIC50: 22.9nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174389(1-(2-Chloro-4-fluoro-benzoyl)-3-(5-hydroxy-2-metho...)
Affinity DataIC50: 23nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174381(4-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-2-hyd...)
Affinity DataIC50: 50nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174381(4-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-2-hyd...)
Affinity DataIC50: 50.1nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174379(1-{3-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-...)
Affinity DataIC50: 52.5nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174379(1-{3-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-...)
Affinity DataIC50: 53nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174397(N-{4-Chloro-3-[3-(2-chloro-4,5-difluoro-benzoyl)-u...)
Affinity DataIC50: 60nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174375(N-{3-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-...)
Affinity DataIC50: 60nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174375(N-{3-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-...)
Affinity DataIC50: 60.3nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174397(N-{4-Chloro-3-[3-(2-chloro-4,5-difluoro-benzoyl)-u...)
Affinity DataIC50: 60.3nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174372(1-(2-Chloro-benzoyl)-3-(5-hydroxy-2-methoxy-phenyl...)
Affinity DataIC50: 64.6nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174372(1-(2-Chloro-benzoyl)-3-(5-hydroxy-2-methoxy-phenyl...)
Affinity DataIC50: 65nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174366(1-(2-Chloro-4-fluoro-benzoyl)-3-[4-(1H-tetrazol-5-...)
Affinity DataIC50: 79.4nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174366(1-(2-Chloro-4-fluoro-benzoyl)-3-[4-(1H-tetrazol-5-...)
Affinity DataIC50: 80nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174384(5-Chloro-4-[3-(2-chloro-4,5-difluoro-benzoyl)-urei...)
Affinity DataIC50: 89.1nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174384(5-Chloro-4-[3-(2-chloro-4,5-difluoro-benzoyl)-urei...)
Affinity DataIC50: 90nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174378(1-(2-Chloro-4-fluoro-benzoyl)-3-(3,4-dihydroxy-phe...)
Affinity DataIC50: 120nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174378(1-(2-Chloro-4-fluoro-benzoyl)-3-(3,4-dihydroxy-phe...)
Affinity DataIC50: 120nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174373(5-Chloro-4-[3-(2,4-dichloro-benzoyl)-ureido]-2-hyd...)
Affinity DataIC50: 150nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174405(4-[3-(2-Chloro-4-fluoro-benzoyl)-ureido]-3-trifluo...)
Affinity DataIC50: 150nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174405(4-[3-(2-Chloro-4-fluoro-benzoyl)-ureido]-3-trifluo...)
Affinity DataIC50: 151nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174373(5-Chloro-4-[3-(2,4-dichloro-benzoyl)-ureido]-2-hyd...)
Affinity DataIC50: 151nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174362(4-[3-(2-Chloro-4-fluoro-benzoyl)-ureido]-2-hydroxy...)
Affinity DataIC50: 158nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174403(1-{4-Chloro-3-[3-(2,4-dichloro-benzoyl)-ureido]-ph...)
Affinity DataIC50: 158nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174374(3-Chloro-4-[3-(2-chloro-4-fluoro-benzoyl)-ureido]-...)
Affinity DataIC50: 158nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174403(1-{4-Chloro-3-[3-(2,4-dichloro-benzoyl)-ureido]-ph...)
Affinity DataIC50: 160nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174362(4-[3-(2-Chloro-4-fluoro-benzoyl)-ureido]-2-hydroxy...)
Affinity DataIC50: 160nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174374(3-Chloro-4-[3-(2-chloro-4-fluoro-benzoyl)-ureido]-...)
Affinity DataIC50: 160nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174368(1-(2-Chloro-4-fluoro-benzoyl)-3-[2-chloro-4-(1H-te...)
Affinity DataIC50: 190nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174368(1-(2-Chloro-4-fluoro-benzoyl)-3-[2-chloro-4-(1H-te...)
Affinity DataIC50: 191nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174380(4-Chloro-3-[3-(2,4-dichloro-benzoyl)-ureido]-N-met...)
Affinity DataIC50: 200nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174380(4-Chloro-3-[3-(2,4-dichloro-benzoyl)-ureido]-N-met...)
Affinity DataIC50: 200nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174388(4-[3-(2-Chloro-4-fluoro-benzoyl)-ureido]-3-methoxy...)
Affinity DataIC50: 209nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174388(4-[3-(2-Chloro-4-fluoro-benzoyl)-ureido]-3-methoxy...)
Affinity DataIC50: 210nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174369(1-(2-Chloro-4,5-difluoro-benzoyl)-3-[2-methoxy-4-(...)
Affinity DataIC50: 250nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174369(1-(2-Chloro-4,5-difluoro-benzoyl)-3-[2-methoxy-4-(...)
Affinity DataIC50: 251nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174385(3-[3-(2,4-Dichloro-benzoyl)-ureido]-4-methoxy-N-me...)
Affinity DataIC50: 300nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174395(4-[3-(2-Chloro-4-fluoro-benzoyl)-ureido]-3-methoxy...)
Affinity DataIC50: 300nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174395(4-[3-(2-Chloro-4-fluoro-benzoyl)-ureido]-3-methoxy...)
Affinity DataIC50: 302nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174385(3-[3-(2,4-Dichloro-benzoyl)-ureido]-4-methoxy-N-me...)
Affinity DataIC50: 302nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174365(4-[3-(2,4-Dichloro-benzoyl)-ureido]-3-methoxy-N-me...)
Affinity DataIC50: 407nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174365(4-[3-(2,4-Dichloro-benzoyl)-ureido]-3-methoxy-N-me...)
Affinity DataIC50: 410nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174391(3-Chloro-4-[3-(2,4-dichloro-benzoyl)-ureido]-benzo...)
Affinity DataIC50: 417nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174391(3-Chloro-4-[3-(2,4-dichloro-benzoyl)-ureido]-benzo...)
Affinity DataIC50: 420nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174396(4-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-3-(2,...)
Affinity DataIC50: 447nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174396(4-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-3-(2,...)
Affinity DataIC50: 450nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174398(4-[3-(2,4-Dichloro-benzoyl)-ureido]-3-methoxy-benz...)
Affinity DataIC50: 510nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174404(4-[3-(2-Chloro-4-fluoro-benzoyl)-ureido]-2-hydroxy...)
Affinity DataIC50: 510nMpH: 7.2Assay Description:Inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate upon incubating for 40 min at 25 de...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174398(4-[3-(2,4-Dichloro-benzoyl)-ureido]-3-methoxy-benz...)
Affinity DataIC50: 513nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Sanofi-Aventis Deutschland

Curated by ChEMBL
LigandPNGBDBM50174404(4-[3-(2-Chloro-4-fluoro-benzoyl)-ureido]-2-hydroxy...)
Affinity DataIC50: 513nMpH: 7.2Assay Description:Logarithmic inhibitory concentration against human liver glycogen phosphorylase enzyme by the addition of glucose-1-phosphate and incubated for 40 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 85 total ) | Next | Last >>
Jump to: